The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Main Page: Medical News Roundups and more Medical Device and Biotech/Pharmaceutical News Medical Meetings and Conventions Calendar Message Boards for Medical Sales and Marketing Professionals, Distributors and Independent Sales Reps in Devices, Biopharmaceuticals and Diagnostics Medical Device Companies, Biotech/Pharmaceutical Companies, Distributors and Independent Sales Reps Members sections: News Roundups, News Archives, SuperSearch, Directory of Medical Sales and Marketing Professionals
Healthcare Sales & Marketing Network celebrates twelve years serving the medical device, biopharmaceutical and diagnostics community!
Share/Bookmark

 
 Roundups:   Bio/Pharma | Devices | Diagnostics | Cardiology | Oncology | Neuro | Ortho | FDA | Personnel | M&A
Generics | Interventional | Radiology | Regenerative | Endocrinology | Monitoring | Venture Capital


  
   
 Healthcare Industry NewsFeed
Search hints >>    
     
 

 

 Search for:  "zolpidem" 

Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review
HSMN NewsFeed, 22 Feb 2010:   Biopharmaceuticals, FDA
[Transcept Pharmaceuticals, Intermezzo, zolpidem, insomnia]

Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
HSMN NewsFeed, 29 Oct 2009:   Biopharmaceuticals, FDA
[Transcept Pharmaceuticals, Intermezzo, zolpidem, insomnia]

Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
HSMN NewsFeed, 16 Mar 2009:   Biopharmaceuticals, FDA
[Orexo, Meda AB, Edluar, Sublinox, zolpidem, insomnia]

Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
HSMN NewsFeed, 2 Feb 2009:   Biopharmaceuticals, Mergers & Acquisitions
[Transcept Pharmaceuticals, Novacea]

Novacea Stockholders Approve Merger With Transcept
HSMN NewsFeed, 27 Jan 2009:   Biopharmaceuticals, Mergers & Acquisitions
[Novacea, Transcept Pharmaceuticals]

Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
HSMN NewsFeed, 22 Oct 2008:   Biopharmaceuticals
[Transcept Pharmaceuticals, Novacea, Intermezzo, zolpidem, insomnia]

Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
HSMN NewsFeed, 1 Oct 2008:   Biopharmaceuticals, Drug Delivery, FDA
[Transcept Pharmaceuticals, Intermezzo, zolpidem, Bimucoral, insomnia]

Ranbaxy Statement on FDA Letters
HSMN NewsFeed, 17 Sep 2008:   Biopharmaceuticals, FDA
[Ranbaxy Laboratories]

Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
HSMN NewsFeed, 10 Jun 2008:   Biopharmaceuticals
[sanofi-aventis, Ambien CR, zolpidem, insomnia, major depressive disorder]

Meda and Orexo in a Potential Billion SEK Deal
HSMN NewsFeed, 14 Apr 2008:   Biopharmaceuticals, Acquisitions
[Meda AB, Orexo, Sublinox, OX-NLA, cetirizine, zolpidem, insomnia]

NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
HSMN NewsFeed, 23 Jan 2008:   Biopharmaceuticals, Drug Delivery, FDA
[NovaDel Pharma, ZolpiMist, zolpidem, insomnia]

Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
HSMN NewsFeed, 4 Jan 2008:   Biopharmaceuticals
[sanofi-aventis, Ambien, zolpidem, insomnia, generalized anxiety disorder]

New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
HSMN NewsFeed, 24 Oct 2007:   Biopharmaceuticals
[sanofi-aventis, AMBIEN CR, zolpidem, Insomnia]

Orexo Shows Positive Results in Completed Comparative Phase III Profile Study of the Sublinox(TM) Sleep Aid Involving Insomnia Patients
HSMN NewsFeed, 1 Oct 2007:   Biopharmaceuticals
[Orexo, Sublinox, OX22, insomnia]

Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
HSMN NewsFeed, 25 Jul 2007:   Biopharmaceuticals, Personnel
[NovaDel Pharma]

TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
HSMN NewsFeed, 22 Jun 2007:   Biopharmaceuticals
[Transcept Pharmaceuticals, TransOral Pharmaceuticals]

Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
HSMN NewsFeed, 26 Apr 2007:   Biopharmaceuticals, Generics, FDA
[Ranbaxy, Zolpidem, Ambien , sanofi-aventis]

Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
HSMN NewsFeed, 25 Apr 2007:   Biopharmaceuticals, Generics, FDA
[Dr. Reddy's Laboratories, Zolpidem, Sanofi-Aventis, Ambien]

Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
HSMN NewsFeed, 24 Apr 2007:   Biopharmaceuticals, Generics
[Roxane Laboratories, Zolpidem, AMBIEN, Sanofi-Aventis]

Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
HSMN NewsFeed, 23 Apr 2007:   Biopharmaceuticals, Generics, Distribution
[Prasco Laboratories, sanofi-aventis, Zolpidem, Ambien]

Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
HSMN NewsFeed, 23 Apr 2007:   Biopharmaceuticals, Generics, FDA
[Caraco Pharmaceutical, Zolpidem, Ambien, sanofi-aventis]

Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed, 23 Apr 2007:   Biopharmaceuticals, Generics, FDA
[Mylan Laboratories, Mylan Pharmaceuticals, Zolpidem, Sanofi-Aventis, Ambien]

Barr Confirms Patent Challenge of Ambien CR(R)
HSMN NewsFeed, 6 Apr 2007:   Biopharmaceuticals, Generics, FDA, Litigation
[Barr Pharmaceuticals, sanofi-aventis, Ambien CR, Zolpidem]

NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
HSMN NewsFeed, 23 Mar 2007:   Biopharmaceuticals
[NovaDel Pharma, Zensana, ondansetron]

TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
HSMN NewsFeed, 6 Mar 2007:   Biopharmaceuticals, Venture Capital
[TransOral Pharmaceuticals]

NovaDel Pharma Announces the Completion of Its Executive Team
HSMN NewsFeed, 26 Feb 2007:   Biopharmaceuticals, Personnel
[NovaDel Pharma]

Successful Proof-of-Concept With Actelion's Orexin Receptor Antagonist in Patients Suffering From Primary Insomnia -- First Demonstration of Key Role of Orexin System in Humans Suffering From Sleep Disorders
HSMN NewsFeed, 5 Feb 2007:   Biopharmaceuticals
[Actelion, ACT-078573, insomnia, Orexin]

NovaDel Pharma Receives FDA Approval of NitroMist(TM)
HSMN NewsFeed, 3 Nov 2006:   Biopharmaceuticals, Drug Delivery, FDA, Cardiology
[NovaDel Pharma, NitroMis, Nitroglycerin Lingual Aerosol, angina]

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate extended- release) Tablets C(IV) for up to 24 Weeks
HSMN NewsFeed, 12 Jul 2006:   Biopharmaceuticals
[sanofi-aventis, AMBIEN CR, zolpidem]

Statement Responding to Recent Media Reports Regarding Appropriate Use of AMBIEN(R) (zolpidem tartrate) CIV in the US
HSMN NewsFeed, 20 Mar 2006:   Biopharmaceuticals
[sanofi-aventis, AMBIEN, zolpidem]




Members click here for search results from The Network Archive (password required) Additional items found:
The Network Archive contains 16 additional items
matching: zolpidem
<< Members - click the icon at left to display.
 
     
 
     

 

 

 HOME    •    NEWSFEED    •     MEETINGS & CONVENTIONS    •    FORUM    •    LINKS    •    TOP   
Copyright © 1998-2010 The Healthcare Sales & Marketing Network. All rights reserved.
The Healthcare Sales & Marketing Network is a registered trademark of Healthcare Sales & Marketing Network, LLC.
Powered by Redhat Enterprise Linux 4ES